Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
88.9 CHF | -0.68% | +1.71% | +4.69% |
12:32pm | Morphosys says takeover by Novartis on course after report of drug safety concern | RE |
26/04 | NOVARTIS AG : Receives a Buy rating from Jefferies | ZD |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+4.69% | 200B | |
+25.84% | 661B | |
+26.74% | 566B | |
-6.67% | 352B | |
+20.41% | 332B | |
+2.72% | 283B | |
+13.51% | 231B | |
-9.41% | 195B | |
-5.22% | 145B | |
-10.70% | 144B |
- Stock Market
- Equities
- NOVN Stock
- News Novartis AG
- Novartis : Signs Development, Distribution Deal With BeiGene For Tislelizumab